Create and deliver bespoke Real-World Insights (RWI) projects with a range of flexible options and services tailored to your unique requirements
At QIAGEN, we don’t just deliver real-world data, we leverage the latest technology, advanced analytics and clinical knowledge to generate insights that enable accelerated market access for new drug therapies.
With QIAGEN RWI, you can use real-world data to:
QIAGEN’s RWI portfolio combines robust real-world data from over 160,000 cancer cases and advanced analytics to achieve better decisions faster in early drug and test development.
To access RWI, you can:
Do you have novel questions, hypotheses, and hurdles to overcome? Our team of scientists, bioinformaticists, and clinicians can help you strategize, customize, and deliver within your timeline.
Choose the best biomarkers and cancer indications for your molecularly targeted therapies
Identify appropriate patient cohorts and enhance your CDx design to improve stratification and success
Expand beyond the one biomarker, one drug paradigm with expert molecular profiling and drug-response analyses